Pictet Asset Management Sa Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Pictet Asset Management Sa

  • $83.4 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$83.14 - $145.99 $24 Million - $42.2 Million
-289,186 Reduced 56.81%
219,848 $32 Million
Q1 2022

May 13, 2022
SELL
$110.08 - $142.92 $22.7 Million - $29.4 Million
-205,989 Reduced 28.81%
509,034 $60.4 Million
Q4 2021

Feb 10, 2022
SELL
$99.73 - $148.48 $1.77 Million - $2.63 Million
-17,701 Reduced 2.42%
715,023 $98.5 Million
Q3 2021

Nov 12, 2021
BUY
$98.85 - $138.91 $72.4 Million - $102 Million
732,724 New
732,724 $102 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email